Cerebral vasospasm pharmacological treatment: An update

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Siasios, Ioannis ^a   Kapsalaki, Eftychia Z ^a   Fountas, Kostas N ^a,b  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; CLAZOSENTAN; DANTROLENE; ERYTHROPOIETIN; FASUDIL; INTERLEUKIN 6; MAGNESIUM; MAGNESIUM SULFATE; NICARDIPINE; NIMODIPINE; NITRIC OXIDE; PAPAVERINE; PLACEBO; PRAVASTATIN; PROSTACYCLIN; PROTEIN S100B; RECOMBINANT ERYTHROPOIETIN; SILDENAFIL; SIMVASTATIN; SODIUM NITRITE; TREHALOSE; VON WILLEBRAND FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTERIAL PRESSURE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; BRADYCARDIA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTINUOUS INFUSION; CONTROLLED DRUG RELEASE; CONVULSION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPERIMENTAL MONKEY; EXPERIMENTAL RABBIT; HUMAN; HYPOCALCEMIA; HYPOTENSION; LENGTH OF STAY; LIVER FUNCTION; LOW DRUG DOSE; LUNG COMPLICATION; MAGNESIUM BLOOD LEVEL; MORTALITY; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SUBARACHNOID HEMORRHAGE; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VASOSPASM;

EID: 84874629331     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/571328     Document Type: Review

References (159)

1. Broderick J. P., Brott T., Tomsick T., Huster G., Miller R., The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. The New England Journal of Medicine 1992 326 11 733 736 2-s2.0-0026512113
2. Ingall T., Asplund K., Mahonen M., Bonita R., A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000 31 5 1054 1061 2-s2.0-0034098854 (Pubitemid 30253525)
3. Ho H. W., Batjer H. H., Batjer H. H., Aneurysmal subarachnoid hemorrhage: pathophysiology and sequelae. Disease 1997 Lippincott-Raven 889 899
4. Sudlow C. L. M., Warlow C. P., Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997 28 3 491 499 2-s2.0-0030893956 (Pubitemid 27118367)
5. Kiyohara Y., Ueda K., Hasuo Y., Wada J., Kawano H., Kato I., Sinkawa A., Ohmura T., Iwamoto H., Omae T., Fujishima M., Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 1989 20 9 1150 1155 2-s2.0-0024448115 (Pubitemid 19226907)
6. Sarti C., Tuomilehto J., Salomaa V., Sivenius J., Kaarsalo E., Narva E. V., Salmi K., Torppa J., Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 1991 22 7 848 853 2-s2.0-0025899465
7. Kassell N. F., Torner J. C., The international cooperative study on timing of aneurysm surgery-an update. Stroke 1984 15 3 566 570 2-s2.0-0021262235 (Pubitemid 14105977)
8. Schievink W., Intracranial aneurysms. The New England Journal of Medicine 1997 336 28 40 (Pubitemid 26428285)
9. Ecker A., Riemenschneider P. A., Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. Journal of neurosurgery 1951 8 6 660 667 2-s2.0-0001337612
10. Robertson E. G., Cerebral lesions due to intracranial aneurysms. Brain 1949 72 2 150 185 2-s2.0-77957175548 10.1093/brain/72.2.150
11. Fisher C. M., Roberson G. H., Ojemann R. G., Cerebral vasospasm with ruptured saccular aneurysm-the clinical manifestations. Neurosurgery 1977 1 3 245 248 2-s2.0-0017549862
12. Hop J. W., Rinkel G. J. E., Algra A., Van Gijn J., Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997 28 3 660 664 2-s2.0-0030890029 (Pubitemid 27118394)
13. Broderick J. P., Brott T. G., Duldner J. E., Tomsick T., Leach A., Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994 25 7 1342 1347 2-s2.0-0028365713 (Pubitemid 24198577)
14. Biller J., Godersky J. C., Adams H. P. Jr., Management of aneurysmal subarachnoid hemorrhage. Stroke 1988 19 10 1300 1305 2-s2.0-0023678665
15. Treggiari-Venzi M. M., Suter P. M., Romand J. A., Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001 48 2 249 262 2-s2.0-0035101570 (Pubitemid 32164863)
16. Kassell N. F., Torner J. C., Haley E. C., Jane J. A., Adams H. P. Jr., Kongable G. L., The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. Journal of Neurosurgery 1990 73 1 18 36 2-s2.0-0025356788 (Pubitemid 20206379)
17. Kassell N. F., Torner J. C., Jane J. A., Haley E. C., Adams H. P. Jr., The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. Journal of Neurosurgery 1990 73 1 37 47 2-s2.0-0025323941 (Pubitemid 20206380)
18. Solenski N. J., Haley E. C., Kassell N. F., Kongable G., Germanson T., Truskowski L., Torner J. C., Spetzler R. F., Selman W. R., Warf B., Barnett G. H., Solomon R. A., Friedman A. H., Campbell R. L., Horner T., Nauta H. J., Heros R. C., Muizelaar J. P., Mohr G., Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Critical Care Medicine 1995 23 6 1007 1017 2-s2.0-0029061064 10.1097/00003246-199506000-00004
19. Adams H. P. Jr., Kassell N. F., Torner J. C., Haley E. C., Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the cooperative aneurysm study. Neurology 1987 37 10 1586 1591 2-s2.0-0023630603 (Pubitemid 17163577)
20. Wartenberg K. E., Schmidt M., Fernandez A., Frontera J. A., Claassen J., Ostapkovich N. D., Badjatia N., Palestrant D., Parra A., Mayer S. A., Symptomatic vasospasm after subarachnoid hemorrhage: predictors, associated complications, and impact on outcome. International Stroke Conference February 2007 San Francisco, Calif, USA
21. Johnston S. C., Selvin S., Gress D. R., The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998 50 5 1413 1418 2-s2.0-0031816177 (Pubitemid 28240362)
22. Rosenorn J., Eskesen V., Schmidt K., Espersen J. O., Haase J., Harmsen A., Hein O., Knudsen V., Midholm S., Marcussen E., Rasmussen P., Ronde R., Voldby B., Hansen L., Clinical features and outcome in 1076 patients with ruptured intracranial saccular aneurysms: a prospective consecutive study. British Journal of Neurosurgery 1987 1 1 33 45 2-s2.0-0023597511
23. Säveland H., Sonesson B., Ljunggren B., Brandt L., Outcome evaluation following subarachnoid hemorrhage. Neurosurg 1986 64 2 191 196 (Pubitemid 16140330)
24. Kassell N. F., Sasaki T., Colohan A. R. T., Nazar G., Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985 16 4 562 572 2-s2.0-0021873601 (Pubitemid 15007226)
25. Allen G. S., Ahn H. S., Preziosi T. J., Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. The New England Journal of Medicine 1983 308 11 619 624 (Pubitemid 13152325)
26. Washington C. W., Zipfel G. J., Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocritical Care 2011 15 2 312 317 2-s2.0-79960024444 10.1007/s12028-011-9594- 8
27. Sehba F. A., Schwartz A. Y., Chereshnev I., Bederson J. B., Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2000 20 3 604 611 2-s2.0-0034104821 (Pubitemid 30164904)
28. Pluta R. M., Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005 105 1 23 56 2-s2.0-11044230424 10.1016/j.pharmthera.2004.10.002 (Pubitemid 40044766)
29. Goretski J., Hollochert T. C., Trapping of nitric oxide produced during denitrification by extracellular hemoglobin. The Journal of Biological Chemistry 1998 263 2316 2323
30. Ignarro L., Biosynthesis and metabolism of endothelium-derived nitric oxide. Annual Review of Pharmacology and Toxicology 1990 30 535 560
31. Pluta R. M., Thompson B. G., Dawson T. M., Snyder S. H., Boock R. J., Oldfield E. H., Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. Journal of Neurosurgery 1996 84 4 648 654 2-s2.0-0029995008 (Pubitemid 26104234)
32. Hino A., Tokuyama Y., Weir B., Takeda J., Yano H., Bell G. I., Macdonald R. L., Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 1996 39 3 562 568 2-s2.0-0029744523 (Pubitemid 26292030)
33. Jung C. S., Iuliano B. A., Harvey-White J., Espey M. G., Oldfield E. H., Pluta R. M., Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery 2004 101 5 836 842 2-s2.0-7244261765 (Pubitemid 39430979)
34. Woszczyk A., Deinsberger W., Böker D. K., Raabe A., Seifert V., Dóczi T., Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochirurgica 2003 145 4 257 264 2-s2.0-0038705318 10.1007/s00701-003-0004-7 (Pubitemid 36560922)
35. Thomas J. E., Nemirovsky A., Zelman V., Giannotta S. L., Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 1997 40 6 1245 1249 2-s2.0-0030951973 10.1097/00006123-199706000-00026 (Pubitemid 27251677)
36. Chow M., Dumont A. S., Kassell N. F., Seifert V., Zimmermann M., Elliott J. P., Awad I. A., Dempsey R. J., Hodge C. J., Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 2002 51 6 1333 1342 2-s2.0-0036957842 10.1097/00006123-200212000-00002 (Pubitemid 36098680)
37. Dumont A. S., Dumont R. J., Chow M. M., Lin C. L., Calisaneller T., Ley K. F., Kassell N. F., Lee K. S., Barrow D. L., Macdonald R. L., Hoh B. L., Ogilvy C. S., Lawton M. T., Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003 53 1 123 135 2-s2.0-0038725119 (Pubitemid 36801515)
38. Fabender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Wendel-Wellner M., Ragoschke A., Kuehl S., Brunner J., Schürer L., Schmiedeck P., Hennerici M., Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 2000 31 12 2971 2975
39. Seifert V., Loffler B. M., Zimmermann M., Roux S., Stolke D., Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. Journal of Neurosurgery 1995 82 1 55 62 2-s2.0-0028888885
40. Juvela S., Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2000 92 3 390 400 2-s2.0-0033997017 (Pubitemid 30112378)
41. Clark J. F., Sharp F. R., Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2006 26 10 1223 1233 2-s2.0-33748945000 10.1038/sj.jcbfm.9600280 (Pubitemid 44435238)
42. Pyne-Geithman G. J., Morgan C. J., Wagner K., Dulaney E. M., Carrozzella J., Kanter D. S., Zuccarello M., Clark J. F., Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2005 25 8 1070 1077 2-s2.0-23044464525 10.1038/sj.jcbfm.9600101 (Pubitemid 41061722)
43. Dumont A. S., Dumont R. J., Chow M. M., Lin C. L., Calisaneller T., Ley K. F., Kassell N. F., Lee K. S., Barrow D. L., Macdonald R. L., Hoh B. L., Ogilvy C. S., Lawton M. T., Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003 53 1 123 135 2-s2.0-0038725119 (Pubitemid 36801515)
44. Provencio J. J., Vora N., Subarachnoid hemorrhage and inflammation: bench to bedside and back. Seminars in Neurology 2005 25 4 435 444 2-s2.0-33644844082 10.1055/s-2005-923537
45. Handa Y., Kabuto M., Kobayashi H., Kawano H., Takeuchi H., Hayashi M., The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991 28 4 542 549 2-s2.0-0025897277
46. Mayberg M. R., Okada T., Bark D. H., Morphologic changes in cerebral arteries after subarachnoid hemorrhage. Neurosurgery Clinics of North America 1990 1 2 417 432 2-s2.0-0025405804
47. Spallone A., Acqui M., Pastore F. S., Guidetti B., Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surgical Neurology 1987 27 3 253 258 2-s2.0-0023138063 (Pubitemid 17030015)
48. Polin R. S., Bavbek M., Shaffrey M. E., Billups K., Bogaev C. A., Kassell N. F., Lee K. S., Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. Journal of Neurosurgery 1998 89 4 559 567 2-s2.0-0031691441 (Pubitemid 28440924)
49. Sullivan G. W., Sarembock I. J., Linden J., The role of inflammation in vascular diseases. Journal of Leukocyte Biology 2000 67 5 591 602
50. Grisham M. B., Granger D. N., Lefer D. J., Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radical Biology and Medicine 1998 25 4-5 404 433 2-s2.0-0032171599 10.1016/S0891-5849(98)00094-X (Pubitemid 28390298)
51. Fassbender K., Hodapp B., Rossol S., Bertsch T., Schmeck J., Schütt S., Fritzinger M., Horn P., Vajkoczy P., Kreisel S., Brunner J., Schmiedek P., Hennerici M., Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. Journal of Neurology Neurosurgery and Psychiatry 2001 70 4 534 537 2-s2.0-0035056594 10.1136/jnnp.70.4.534 (Pubitemid 32269696)
52. Hirashima Y., Nakamura S., Endo S., Kuwayama N., Naruse Y., Takaku A., Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochemical Research 1997 22 10 1249 1255 2-s2.0-0030804604 10.1023/A:1021985030331 (Pubitemid 27440793)
53. Takizawa T., Tada T., Kitazawa K., Tanaka Y., Hongo K., Kameko M., Uemura K. I., Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurological Research 2001 23 7 724 730 2-s2.0-0034790802 10.1179/016164101101199243 (Pubitemid 32952702)
54. Bowman G., Bonneau R. H., Chinchilli V. M., Tracey K. J., Cockroft K. M., A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm. Neurocritical Care 2006 5 3 222 229 2-s2.0-33846961135 10.1385/NCC:5:3:222
55. Bowman G., Dixit S., Bonneau R. H., Chinchilli V. M., Cockroft K. M., Findlay J. M., Schackert G., Macdonald R. L., Connolly E. S. Jr., Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model. Neurosurgery 2004 54 3 719 726 2-s2.0-1542346492 (Pubitemid 38298747)
56. Bederson J. B., Connolly E. S. Jr., Batjer H. H., Dacey R. G., Dion J. E., Diringer M. N., Duldner J. E., Harbaugh R. E., Patel A. B., Rosenwasser R. H., Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke 2009 40 3 994 1025 2-s2.0-62449310759 10.1161/STROKEAHA.108.191395
57. Diringer M. N., Bleck T. P., Hemphill III J. C., Menon D., Shutter L., Vespa P., Bruder N., Connolly E. S. Jr., Citerio G., Gress D., Hänggi D., Hoh B. L., Lanzino G., Le Roux P., Rabinstein A., Schmutzhard E., Stocchetti N., Suarez J. I., Tseng M.-Y., Vergouwen M. D. I., Wolf S., Zipfel G., Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society's multidisciplinary consensus conference. Neurocritical Care 2011 15 2 211 240 10.1007/s12028-011- 9605-9
58. Tettenborn D., Dycka J., Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 1990 21 12 IV85 IV89 2-s2.0-0025650605
59. Tettenborn D., Dycka J., Volberg E., Dudden P., Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Neurochirurgia 1985 28 1 84 86 2-s2.0-0021873297 (Pubitemid 15050412)
60. Ohman J., Dorsch N., Van Gelder J., Murray G. D., Wagenknecht L. E., Furberg C. D., Legault C., Troost B. T., Surgical bleeding and calcium antagonists. British Medical Journal 1995 311 7001 388 389
61. Pickard J. D., Murray G. D., Illingworth R., Shaw M. D. M., Teasdale G. M., Foy P. M., Humphreys P. R. D., Lang D. A., Nelson R., Richards P., Sinar J., Bailey S., Skene A., Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: british aneurysm nimodipine trial. British Medical Journal 1989 298 6674 636 642 2-s2.0-0024515530 (Pubitemid 19088521)
62. Karinen P., Koivukangas P., Ohinmaa A., Koivukangas J., Öhman J., Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 1999 45 4 780 785 2-s2.0-0032857955 (Pubitemid 29467805)
63. Barth M., Capelle H. H., Weidauer S., Weiss C., Münch E., Thomé C., Luecke T., Schmiedek P., Kasuya H., Vajkoczy P., Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007 38 2 330 336 2-s2.0-33846697939 10.1161/01.STR.0000254601.74596.0f (Pubitemid 46188258)
64. Krischek B., Kasuya H., Onda H., Hori T., Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients. Neurologia Medico-Chirurgica 2007 47 9 389 396 2-s2.0-35148877316 10.2176/nmc.47.389
65. Kasuya H., Onda H., Sasahara A., Takeshita M., Hori T., Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005 56 5 895 902 2-s2.0-18244370007
66. Velat G. J., Kimball M. M., Mocco J. D., Hoh B. L., Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurgery 2011 76 5 446 454 10.1016/j.wneu.2011.02.030
67. Connolly E. S. Jr., Rabinstein A. A., Carhuapoma J. R., Derdeyn C. P., Dion J., Higashida R. T., Hoh B. L., Kirkness C. J., Naidech A. M., Ogilvy C. S., Patel A. B., Thompson B. G., Vespa P., Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2012 43 6 1711 1737 10.1161/STR.0b013e3182587839
68. Robinson J. S., Walid M. S., Hyun S., O'Connell R., Menard C., Bohleber B., Computational modeling of HHH therapy and impact of blood pressure and hematocrit. World Neurosurgery 2010 74 2-3 294 296 2-s2.0-78650320074 10.1016/j.wneu.2010.02.059
69. Treggiari M. M., Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care 2011 15 2 329 335
70. Meyer R., Deem S., David Yanez N., Souter M., Lam A., Treggiari M. M., Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocritical Care 2011 14 1 24 36 2-s2.0-79551551802 10.1007/s12028-010-9437-z
71. MacDonald R. L., Kassell N. F., Mayer S., Ruefenacht D., Schmiedek P., Weidauer S., Frey A., Roux S., Pasqualin A., Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008 39 11 3015 3021 2-s2.0-55749089548 10.1161/STROKEAHA.108. 519942
72. Rabinstein A. A., Lanzino G., Wijdicks E. F., Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. The Lancet Neurology 2010 9 5 504 519 2-s2.0-77950606015 10.1016/S1474-4422(10)70087-9
73. Castanares-Zapatero D., Hantson P., Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage. Annals of Intensive Care 1906 1 1, article 12 10.1186/2110-5820-1-12
74. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology 2011 10 7 618 625 2-s2.0-79958803259 10.1016/S1474-4422(11)70108-9
75. MacDonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Frey A., Marr A., Roux S., Kassell N. F., Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocritical Care 2010 13 3 416 424 2-s2.0-78649707804 10.1007/s12028-010-9433-3
76. Macdonald R. L., Higashida R. T., Keller E., Mayer S. A., Molyneux A., Raabe A., Vajkoczy P., Wanke I., Bach D., Frey A., Marr A., Roux S., Kassell N., Randomised trial of clazosentan an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-3). Stroke 2012 43 1463 1469
77. Brewer R. P., Parra A., Lynch J., Chilukuri V., Borel C. O., Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 2001 13 3 202 206 2-s2.0-0034952827 10.1097/00008506-200107000-00004 (Pubitemid 32606414)
78. Chia R. Y., Hughes R. S., Morgan M. K., Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Journal of Clinical Neuroscience 2002 9 3 279 281 2-s2.0-0036345421 10.1054/jocn.2001.1039
79. Barile M., Van De Wyngaert F., Mbia J. J. E., Jativa M., Grandin C., Rooijakkers H., Hantson P., Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage. Intensive Care Medicine 2003 29 7 1182 1185 2-s2.0-0042166187 10.1007/s00134-003-1752-9 (Pubitemid 36918566)
80. Collignon F. P., Friedman J. A., Piepgras D. G., Pichelmann M. A., McIver J. I., Toussaint L. G., McClelland R. L., Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocritical Care 2004 1 4 441 448 2-s2.0-24644521058 10.1385/NCC:1:4:441 (Pubitemid 41278332)
81. Lees K. R., Muir K. W., Ford I., Reid L., Mendelow A. D., Sandercock P. A. G., Bath P. M. W., Chen C., Davis S. M., Phillips S. J., Saver J., Vanhooren G., Forbes C., Murray G., Bone I., Norrie J., Kean S., Robertson M., Murray H., McIlvenna Y., Gardner A., Bradford A., Fenton J., Sakhri A., Rodger M., Sanmuganathan P., Milia P., Chong V., Teasdale E., Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. The Lancet 2004 363 9407 439 445 2-s2.0-2942700683 10.1016/S0140-6736(04)15490-1 (Pubitemid 38210060)
82. Chan M. T. V., Boet R., Ng S. C. P., Poon W. S., Gin T., Magnesium sulfate for brain protection during temporary cerebral artery occlusion. Acta Neurochirurgica, Supplementum 2005 95 107 111 2-s2.0-33644864285 10.1007/3-211-32318-X-23
83. Prevedello D. M. S., Cordeiro J. G., De Morais A. L., Saucedo N. S., Chen I. B., Araújo J. C., Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006 65 1 S1 S1 2-s2.0-30944436451 10.1016/j.surneu.2005.11.035 (Pubitemid 43112129)
84. Yahia A. M., Kirmani J. F., Qureshi A. I., Guterman L. R., Hopkins L. N., The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocritical Care 2005 3 1 16 23 2-s2.0-24644473051 10.1385/Neurocrit. Care2005;3:16-23 (Pubitemid 41278388)
85. Boet R., Chan M. T. V., Poon W. S., Wong G. K. C., Wong H. T., Gin T., Intravenous magnesium sulfate to improve outcome after aneurysmal subarachnoid hemorrhage: interim report from a pilot study. Acta Neurochirurgica, Supplementum 2005 95 263 264 2-s2.0-33644848789 10.1007/3-211-32318-X-53
86. Wong G. K. C., Chan M. T. V., Boet R., Poon W. S., Gin T., Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. Journal of Neurosurgical Anesthesiology 2006 18 2 142 148 2-s2.0-33646848055 10.1097/00008506-200604000-00009 (Pubitemid 44510114)
87. Stippler M., Crago E., Levy E. I., Kerr M. E., Yonas H., Horowitz M. B., Kassam A., Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. Journal of Neurosurgery 2006 105 5 723 729 2-s2.0-33750686615 (Pubitemid 44703935)
88. Muroi C., Terzic A., Fortunati M., Yonekawa Y., Keller E., Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surgical Neurology 2008 69 1 33 39 2-s2.0-36549001723 10.1016/j.surneu.2007.07.015 (Pubitemid 350181007)
89. Zhao X. D., Zhou Y. T., Zhang X., Zhuang Z., Shi J. X., A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate. Journal of Clinical Neuroscience 2009 16 11 1394 1397 2-s2.0-70449535520 10.1016/j.jocn.2009.05.001
90. Wong G. K. C., Poon W. S., Chan M. T. V., Boet R., Gin T., Ng S. C. P., Zee B. C. Y., Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010 41 5 921 926 2-s2.0-77951766835 10.1161/STROKEAHA.109.571125
91. Westermaier T., Stetter C., Vince G. H., Pham M., Tejon J. P., Eriskat J., Kunze E., Matthies C., Ernestus R. I., Solymosi L., Roosen K., Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Critical Care Medicine 2010 38 5 1284 1290 2-s2.0-77951622468 10.1097/CCM.0b013e3181d9da1e
92. Suarez J. I., Magnesium sulfate administration in subarachnoid hemorrhage. Neurocritical Care 2011 15 2 302 307 10.1007/s12028-011-9603-y
93. Muroi C., Burkhardt J.-K., Hugelshofer M., Seule M., Mishima K., Keller E., Magnesium and the inflammatory response: potential pathophysiological implications in the management of patients with aneurysmal subarachnoid hemorrhage? Magnesium Research 2012 25 2 64 71 10.1684/mrh.2012.0314
94. Mees S. M. D., Algra A., Vandertop W. P., Van Kooten F., Kuijsten H. A. J. M., Boiten J., Van Oostenbrugge R. J., Salman R. A.-S., Lavados P. M., Rinkel G. J. E., Van Den Bergh W. M., Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. The Lancet 2012 380 9836 44 49 10.1016/S0140-6736(12)60724-7
95. Tseng M. Y., Czosnyka M., Richards H., Pickard J. D., Kirkpatrick P. J., Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005 36 8 1627 1632 2-s2.0-23244432198 10.1161/01.STR.0000176743.67564.5d (Pubitemid 41098752)
96. Lynch J. R., Wang H., McGirt M. J., Floyd J., Friedman A. H., Coon A. L., Blessing R., Alexander M. J., Graffagnino C., Warner D. S., Laskowitz D. T., Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005 36 9 2024 2026 2-s2.0-24644488726 10.1161/01.STR.0000177879.11607.10 (Pubitemid 41266547)
97. Iwabuchi S., Yokouchi T., Hayashi M., Sato K., Saito N., Hirata Y., Harashina J., Nakayama H., Akahata M., Ito K., Kimura H., Aoki K., Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage: experience of 90 cases. Acta Neurochirurgica, Supplement 2011 110 2 179 181
98. Zhao J., Zhou D., Guo J., Ren Z., Zhou L., Wang S., Zhang Y., Xu B., Zhao K., Wang R., Mao Y., Xu B., Zhang X., Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurologia Medico-Chirurgica 2011 51 10 679 683 10.2176/nmc.51.679
99. Nakamura T., Matsui T., Hosono A., Okano A., Fujisawa N., Tsuchiya T., Indo M., Suzuki Y., Oya S., Chang H. S., Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH. Acta Neurochirurgica, Supplementum 2013 115 81 85 10.1007/978-3-7091-1192-5-18
100. Liu G. J., Wang Z. J., Wang Y. F., Xu L. L., Wang X. L., Liu Y., Luo G. J., He G. H., Zeng Y. J., Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. European Journal of Clinical Pharmacology 2012 68 2 131 139 10.1007/s00228-011-1100-x
101. Enomoto Y., Yoshimura S., Yamada K., Iwama T., Convulsion during intra-arterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage. Neurologia Medico-Chirurgica 2010 50 1 7 11 2-s2.0-76749170849 10.2176/nmc.50.7
102. Kasuya H., Onda H., Sasahara A., Takeshita M., Hori T., Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005 56 5 895 902 2-s2.0-18244370007
103. Barth M., Capelle H. H., Weidauer S., Weiss C., Münch E., Thomé C., Luecke T., Schmiedek P., Kasuya H., Vajkoczy P., Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007 38 2 330 336 2-s2.0-33846697939 10.1161/01.STR.0000254601.74596.0f (Pubitemid 46188258)
104. Krischek B., Kasuya H., Onda H., Hori T., Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients. Neurologia Medico-Chirurgica 2007 47 9 389 394 2-s2.0-35148877316 10.2176/nmc.47.389
105. Barth M., Thomé C., Schmiedek P., Weiss C., Kasuya H., Vajkoczy P., Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants: clinical article. Journal of Neurosurgery 2009 110 5 955 960 2-s2.0-66849089784 10.3171/2008.2.17670
106. Schneider U. C., Dreher S., Hoffmann K.-T., Schmiedek P., Kasuya H., Vajkoczy P., The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment. Acta Neurochirurgica 2011 153 11 2119 2125 10.1007/s00701-011-1129-8
107. Thomé C., Seiz M., Schubert G. A., Barth M., Vajkoczy P., Kasuya H., Schmiedek P., Nicardipine pellets for the prevention of cerebral vasospasm. Acta Neurochirurgica, Supplement 2011 110 2 209 211 2-s2.0-79952279237
108. Barth M., Pena P., Seiz M., Thome C., Muench E., Weidauer S., Hattingen E., Kasuya H., Schmiedek P., Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage. British Journal of Neurosurgery 2011 25 6 677 683
109. Kasuya H., Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial. Acta Neurochirurgica, Supplementum 2013 115 41 44 10.1007/978-3-7091-1192-5-9
110. Van Den Bergh W. M., Dijkhuizen R. M., Rinkel G. J. E., Potentials of magnesium treatment in subarachnoid haemorrhage. Magnesium Research 2004 17 4 301 313 2-s2.0-12744263413
111. MacDonald R. L., Curry D. J., Aihara Y., Zhang Z. D., Jahromi B. S., Yassari R., Magnesium and experimental vasospasm. Journal of Neurosurgery 2004 100 1 106 110 2-s2.0-0346993067 (Pubitemid 38017822)
112. Westermaier T., Zausinger S., Baethmann A., Schmid-Elsaesser R., Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochirurgica 2005 147 5 525 532 2-s2.0-18044395508 10.1007/s00701-005-0496-4 (Pubitemid 40603116)
113. Sharma N., Cho D. H., Kim S. Y., Bhattarai J. P., Hwang P. H., Han S. K., Magnesium sulfate suppresses L-type calcium currents on the basilar artery smooth muscle cells in rabbits. Neurological Research 2012 34 3 291 296 10.1179/1743132812Y.0000000016
114. Boet R., Mee E., Magnesium sulfate in the management of patients with fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000 47 3 602 607 2-s2.0-0034521189 (Pubitemid 32044706)
115. Amin-Hanjani S., Stagliano N. E., Yamada M., Huang P. L., Liao J. K., Moskowitz M. A., Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001 32 4 980 985 2-s2.0-0035073930 (Pubitemid 32285170)
116. Laufs U., La Fata V., Liao J. K., Inhibition of 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. The Journal of Biological Chemistry 1997 272 50 31725 31729 2-s2.0-0031451344 10.1074/jbc.272.50.31725 (Pubitemid 28013321)
117. Yamada M., Huang Z., Dalkara T., Endres M., Laufs U., Waeber C., Huang P. L., Liao J. K., Moskowitz M. A., Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. Journal of Cerebral Blood Flow and Metabolism 2000 20 4 709 717 2-s2.0-0034006811 (Pubitemid 30217509)
118. Tseng M. Y., Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocritical Care 2011 15 2 298 301 2-s2.0-79961120032 10.1007/s12028-011-9596-6
119. Diringer M. N., Bleck T. P., Hemphill III J. C., Menon D., Shutter L.,
120. Satoh S.-I., Takayasu M., Kawasaki K., Ikegaki I., Hitomi A., Yano K., Shibuya M., Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage. Journal of Pharmacological Sciences 2012 118 1 92 98 10.1254/jphs.11075FP
121. Butler W. E., Peterson J. W., Zervas N. T., Chase S., Kaoutzanis M., Yokota M., Contractile force regulation in chronic cerebral vasospasm. Canadian Journal of Neurological Sciences 1993 20 supplement 1, article S10
122. Nishizawa S., Peterson J. W., Shimoyama I., Uemura K., Loftus C. M., Mayberg M. R., Relation between protein kinase C and calmodulin systems in cerebrovascular contraction: investigation of the pathogenesis of vasospasm after subarachnoid hemorrhage. Neurosurgery 1992 31 4 711 716 2-s2.0-0026707822
123. Sato M., Tani E., Fujikawa H., Kaibuchi K., Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circulation Research 2000 87 3 195 200 2-s2.0-0033879562 (Pubitemid 30626426)
124. Muroi C., Seule M., Mishima K., Keller E., Novel treatments for vasospasm after subarachnoid hemorrhage. Current Opinion in Critical Care 2012 18 2 119 126 10.1097/MCC.0b013e32835075ae
125. Satoh S.-I., Kobayashi T., Hitomi A., Ikegaki I., Suzuki Y., Shibuya M., Yoshida J., Asano T., Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Japanese Journal of Pharmacology 1999 80 1 41 48 10.1254/jjp.80.41 (Pubitemid 29271512)
126. Satoh S. I., Utsunomiya T., Tsurui K., Kobayashi T., Ikegaki I., Sasaki Y., Asano T., Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sciences 2001 69 12 1441 1453 2-s2.0-0035838950 10.1016/S0024-3205(01)01229-2 (Pubitemid 32758711)
127. Satoh S.-I., Yamaguchi T., Hitomi A., Sato N., Shiraiwa K., Ikegaki I., Asano T., Shimokawa H., Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. European Journal of Pharmacology 2002 455 2-3 169 174 10.1016/S0014-2999(02)02619-5 (Pubitemid 35351611)
128. Satoh S. I., Hitomi A., Ikegaki I., Kawasaki K., Nakazono O., Iwasaki M., Mohri M., Asano T., Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. Brain Research Bulletin 2010 81 1 191 195 2-s2.0-71349088554 10.1016/j.brainresbull.2009.08.021
129. Liu P., Liao X., Xiang J., Pan L., Ma L., Continuous intravertebral injection of fasudil hydrochloride in the treatment of cerebral vasospasm. Neurology India 2011 59 2 161 167 2-s2.0-79955460989 10.4103/0028-3886.79127
130. Shibuya M., Effect of fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochirurgica, Supplement 2001 77 201 204 2-s2.0-0035225346 (Pubitemid 33759247)
131. Yano K., Kawasaki K., Hattori T., Tawara S., Toshima Y., Ikegaki I., Sasaki Y., Satoh S.-i., Asano T., Seto M., Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction. European Journal of Pharmacology 2008 594 1-3 77 83 10.1016/j.ejphar.2008.07.045
132. Hitomi A., Satoh S. I., Ikegaki I., Suzuki Y., Shibuya M., Asano T., Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity. Life Sciences 2000 67 16 1929 1939 2-s2.0-0034622967 10.1016/S0024-3205(00)00781-5
133. Ishihara M., Yamanaka K., Nakajima S., Yamasaki M., Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: a serious adverse event. Neuroradiology 2011 54 1 73 75 2-s2.0-79952800033 10.1007/s00234-011-0856-0
134. Chen G., Zhang S., Shi J., Ai J., Hang C., Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 2009 45 3 162 168 2-s2.0-60649106948 10.1016/j.cyto.2008.11.015
135. Zhang J., Zhu Y., Zhou D., Wang Z., Chen G., Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Nrf2-ARE pathway. Cytokine 2010 52 3 252 257 2-s2.0-79953330040
136. Ulusal I., Tari R., Ozturk G., Aycicek E., Aktar F., Kotil K., Bilge T., Kiris T., Dose-dependent ultrastructural and morphometric alterations after erythropoietin treatment in rat femoral artery vasospasm model. Acta Neurochirurgica 2010 152 12 2161 2166 2-s2.0-78651075524 10.1007/s00701-010- 0775-6
137. Tseng M. Y., Hutchinson P. J., Richards H. K., Czosnyka M., Pickard J. D., Erber W. N., Brown S., Kirkpatrick P. J., Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial: clinical article. Journal of Neurosurgery 2009 111 1 171 180 2-s2.0-67650851481 10.3171/2009.3.JNS081332
138. Helbok R., Shaker E., Beer R., Chemelli A., Sojer M., Sohm F., Broessner G., Lackner P., Beck M., Zangerle A., Pfausler B., Thome C., Schmutzhard E., High dose Erythropoietin increases brain tissue oxygen tension in Severe Vasospasm after Subarachnoid Hemorrhage. BMC Neurology 2012 12, article 32 10.1186/1471-2377-12-32
139. Turner J. D., Mammis A., Prestigiacomo C. J., Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurgery 2010 73 5 500 507 2-s2.0-77957108535 10.1016/j.wneu.2010.02.026
140. Xiong Y., Chopp M., Lee C. P., Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury. Neurological Research 2009 31 5 496 502 2-s2.0-67650165296 10.1179/174313208X353703
141. Maiese K., Zhao Z. C., Hou J., Yan C. S., Erythropoietin and oxidative stress. Current Neurovascular Research 2008 5 2 125 142 2-s2.0-45249120614 10.2174/156720208784310231 (Pubitemid 351838578)
142. Jerndal M., Forsberg K., Sena E. S., MacLeod M. R., O'Collins V. E., Linden T., Nilsson M., Howells D. W., A systematic review and meta-analysis of erythropoietin in experimental stroke. Journal of Cerebral Blood Flow and Metabolism 2010 30 5 961 968 2-s2.0-77952008909 10.1038/jcbfm.2009.267
143. Omeis I., Jayson N. A., Murali R., Abrahams J. M., Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery. Neurosurgery 2008 63 6 1011 1021 2-s2.0-58149461552 10.1227/01.NEU.0000327574.32000.9A
144. Atalay B., Caner H., Cekinmez M., Ozen O., Celasun B., Altinors N., Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2006 59 5 1102 1108 2-s2.0-33845188745 10.1227/01.NEU.0000245605.22817.44
145. Inoha S., Inamura T., Ikezaki K., Nakamizo A., Amano T., Fukui M., Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Neurological Research 2002 24 6 607 612 2-s2.0-0036715708 10.1179/016164102101200447 (Pubitemid 35024492)
146. Gokce C., Gulsen S., Yilmaz C., Guven G., Caner H., Altinors N., The effect of the sildenafil citrate on cerebral vasospasm and apoptosis following experimental subarachnoid hemorrhage in rats. Journal of Neurosurgical Sciences 2010 54 1 29 37 2-s2.0-77954747208
147. Clatterbuck R. E., Gailloud P., Tierney T., Clatterbuck V. M., Murphy K. J., Tamargo R. J., Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. Journal of Neurosurgery 2005 103 4 745 751 2-s2.0-32044435415 (Pubitemid 43193884)
148. Pluta R. M., Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005 105 1 23 56 2-s2.0-11044230424 10.1016/j.pharmthera.2004.10.002 (Pubitemid 40044766)
149. Sobey C. G., Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions or therapy. Clinical and Experimental Pharmacology and Physiology 2001 28 11 926 929 2-s2.0-0035171653 10.1046/j.1440-1681.2001.03550.x (Pubitemid 33071069)
150. Fathi A. R., Bakhtian K. D., Pluta R. M., The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochirurgica, Supplement 2011 110 1 93 97 2-s2.0-79952278806
151. Fathi A. R., Pluta R. M., Bakhtian K. D., Qi M., Lonser R. R., Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates: laboratory investigation. Journal of Neurosurgery 2011 115 6 1213 1220 10.3171/2011.7.JNS11390
152. Osuka K., Watanabe Y., Yasuda M., Takayasu M., Adiponectin activates endothelial nitric oxide synthase through AMPK signaling after subarachnoid hemorrhage. Neuroscience Letters 2012 514 1 2 5 10.1016/j.neulet.2011.12.041
153. Pradilla G., Garzon-Muvdi T., Ruzevick J. J., Bender M., Edwards L., Momin E. N., Thompson R. C., Tamargo R. J., Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage. Neurosurgery 2012 70 3 747 757
154. Majidi S., Grigoryan M., Tekle W. G., Qureshi A. I., Intra-arterial dantrolene for refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurocritical Care 2012 17 2 245 249 10.1007/s12028-012-9737-6
155. Muehlschlegel S., Rordorf G., Bodock M., Sims J. R., Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series. Neurocritical Care 2009 10 1 116 121 2-s2.0-63249115958 10.1007/s12028-008-9132-5
156. Muehlschlegel S., Rordorf G., Sims J., Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke 2011 42 5 1301 1306 2-s2.0-79955477320 10.1161/STROKEAHA.110.603159
157. Woitzik J., Dreier J. P., Hecht N., Fiss I., Sandow N., Major S., Winkler M., Dahlem Y. A., Manville J., Diepers M., Muench E., Kasuya H., Schmiedek P., Vajkoczy P., Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2012 32 2 203 212 10.1038/jcbfm.2011.169
158. Echigo R., Shimohata N., Karatsu K., Yano F., Kayasuga-Kariya Y., Fujisawa A., Ohto T., Kita Y., Nakamura M., Suzuki S., Mochizuki M., Shimizu T., Chung U.-I., Sasaki N., Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. Journal of Translational Medicine 2012 10 1, article 80 10.1186/1479-5876-10-80
159. Rasmussen R., Wetterslev J., Stavngaard T., Skjøth-Rasmussen J., Grände P. O., Olsen N. V., Romner B., The effects of continuous prostacyclin infusion on regional blood flow and cerebral vasospasm following subarachnoid haemorrhage: study protocol for a randomised controlled trial. Trials 2012 13, article 102 10.1186/1745-6215-13-102